MedTrace Logo

A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)

NCT01185275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2020-11-27

No results posted yet for this study

Summary

Clinical response, as defined by improvement in asthma quality of life, to bronchial thermoplasty in patients with severe refractory asthma can be predicted through the use of clinical, physiologic, biologic and imaging markers.

Conditions

Interventions

DEVICE

Alair system

Bronchial thermoplasty

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER

  • National Jewish Health

    collaborator OTHER

  • University of Arizona

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • Louisiana State University Health Sciences Center in New Orleans

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Creighton University

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mario Castro, MD, MPH · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01185275 on ClinicalTrials.gov